Sarepta Stock: a promising gene therapy against muscular dystrophy
[ad_1] Therapeutic Sarepta (SRPT) came closer to hatching Wednesday after its gene therapy has shown promise in the treatment of a form of muscular dystrophy. X Today, Sarepta's shares have risen 8.3% to 151.68, more than triple their average volume. The shares are approaching a point of purchase at 169.97 on a cup base that … Read more